A Method for Producing Protein Nanoparticles with Applications in Vaccines.
A practical method is described for synthesizing conjugated protein nanoparticles using thioether (thiol-maleimide) cross-linking chemistry. This method fills the need for a reliable and reproducible synthesis of protein conjugate vaccines for preclinical studies, which can be adapted to produce com...
Main Authors: | David S Jones, Christopher G Rowe, Beth Chen, Karine Reiter, Kelly M Rausch, David L Narum, Yimin Wu, Patrick E Duffy |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4780713?pdf=render |
Similar Items
-
Protein-protein conjugate nanoparticles for malaria antigen delivery and enhanced immunogenicity.
by: Puthupparampil V Scaria, et al.
Published: (2017-01-01) -
Structural and immunological differences in Plasmodium falciparum sexual stage transmission-blocking vaccines comprised of Pfs25-EPA nanoparticles
by: Nicholas J. MacDonald, et al.
Published: (2023-04-01) -
Preclinical evaluations of Pfs25-EPA and Pfs230D1-EPA in AS01 for a vaccine to reduce malaria transmission
by: Kelly M. Rausch, et al.
Published: (2023-07-01) -
Protein-protein conjugation enhances the immunogenicity of SARS-CoV-2 receptor-binding domain (RBD) vaccines
by: Puthupparampil V. Scaria, et al.
Published: (2022-08-01) -
mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune response
by: Puthupparampil V. Scaria, et al.
Published: (2024-01-01)